Cargando…
Impact of cross-coronavirus immunity in post-acute sequelae of COVID-19
Beyond the unpredictable acute illness caused by SARS-CoV-2, one-fifth of infections unpredictably result in long-term persistence of symptoms despite the apparent clearance of infection. Insights into the mechanisms that underlie post-acute sequelae of COVID-19 (PASC) will be critical for the preve...
Autores principales: | Herman, Jonathan D., Atyeo, Caroline, Zur, Yonatan, Cook, Claire E., Patel, Naomi J., Vanni, Kathleen M., Kowalski, Emily N., Qian, Grace, Shadick, Nancy A., Laffenburger, Douglas, Wallace, Zachary S., Sparks, Jeffrey A., Alter, Galit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9536039/ https://www.ncbi.nlm.nih.gov/pubmed/36203557 http://dx.doi.org/10.1101/2022.09.25.22280335 |
Ejemplares similares
-
404. Impact of cross-coronavirus humoral immunity in post-acute sequelae of COVID-19 in systemic autoimmune rheumatic diseases patients
por: Herman, Jonathan, et al.
Publicado: (2023) -
Breakthrough infection after three doses of COVID-19 mRNA vaccine in systemic autoimmune rheumatic diseases: two cases in patients on TNF inhibitor monotherapy
por: Vanni, Kathleen MM, et al.
Publicado: (2022) -
Factors associated with COVID-19 breakthrough infection among vaccinated patients with rheumatic diseases: A cohort study
por: Patel, Naomi J., et al.
Publicado: (2023) -
Coronavirus Disease 2019 Outcomes Among Recipients of Anti‐CD20 Monoclonal Antibodies for Immune‐Mediated Diseases: A Comparative Cohort Study
por: Patel, Naomi J., et al.
Publicado: (2021) -
Evolution of Early SARS-CoV-2 and Cross-Coronavirus Immunity
por: Loos, Carolin, et al.
Publicado: (2020)